Bladder Cancer Trial, Recruiting (NCT06092450)

Bladder Cancer Trial, Recruiting NCT06092450 Sponsor: First Affiliated Hospital of Chongqing Medical University Condition: Bladder Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06092450 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Bladder Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with muscle-invasive bladder cancer, confirmed by a laboratory test, and have had surgery to remove the bladder (radical cystectomy).
You had a CT scan with contrast dye taken less than two weeks before your surgery.
Your full CT scan images and medical records are available and complete.

Who may not be able to join:

You received treatment (such as chemotherapy or radiation) before your surgery to shrink the cancer.
Your bladder cancer is not the most common type (urothelial carcinoma) — meaning it is a rarer type of bladder cancer (confirm with trial site).
Your CT scan images are not clear enough to be used in the study.
Your medical records or follow-up information are missing or incomplete.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 023-89012557

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06092450

Sponsor: First Affiliated Hospital of Chongqing Medical University

Phase: Not Applicable

Status: Recruiting

Condition: Bladder Cancer

Trial contact: 023-89012557

More information: https://clinicaltrials.gov/study/NCT06092450

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with muscle-invasive bladder cancer, confirmed by a laboratory test, and have had surgery to remove the bladder (radical cystectomy).
You had a CT scan with contrast dye taken less than two weeks before your surgery.
Your full CT scan images and medical records are available and complete.

Who may not be able to join:

You received treatment (such as chemotherapy or radiation) before your surgery to shrink the cancer.
Your bladder cancer is not the most common type (urothelial carcinoma) — meaning it is a rarer type of bladder cancer (confirm with trial site).
Your CT scan images are not clear enough to be used in the study.
Your medical records or follow-up information are missing or incomplete.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

First Affiliated Hospital of Chongqing Medical University

Registry

ClinicalTrials.gov

Start date

1 August 2023

Est. completion

1 June 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Overall survival（OS）; Recurrence free survival（RFS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov